Endothelial progenitor cells in vascular repair and remodeling

Pharmacological Research

Volumn 58, Issue 2, 2008, Pages 148-151

  Hristov, Mihail ^a   Weber, Christian ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Angiogenesis; Arterial injury; Coronary artery disease; Stem cells

Indexed keywords

CD133 ANTIGEN; CD14 ANTIGEN; CD34 ANTIGEN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ARTERY INJURY; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CARDIOVASCULAR RISK; CELL DIFFERENTIATION; CELL PROLIFERATION; ENDOTHELIUM CELL; HOMEOSTASIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; TISSUE REGENERATION; TISSUE REPAIR;

ANIMALS; ATHEROSCLEROSIS; BLOOD VESSELS; CELL MOVEMENT; ENDOTHELIAL CELLS; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; REGENERATION; STEM CELLS;

EID: 53249091923     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2008.07.008     Document Type: Article

References (63)

1. Cines D.B., Pollak E.S., Buck C.A., Loscalzo J., Zimmerman G.A., McEver R.P., et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91 (1998) 3527-3561
2. Dignat-George F., and Sampol J. Circulating endothelial cells in vascular disorders: new insights into an old concept. Eur J Haematol 65 (2000) 215-220
3. Hansson G.K., and Inflammation. atherosclerosis, and coronary artery disease. N Engl J Med 352 (2005) 1685-1695
4. Libby P., and Aikawa M. Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Nat Med 8 (2002) 1257-1262
5. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
6. Peichev M., Naiyer A.J., Pereira D., et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95 (2000) 952-958
7. Yoon Y.S., Wecker A., Heyd L., et al. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest 115 (2005) 326-338
8. Rabelink T.J., de Boer H.C., de Koning E.J., and van Zonneveld A.J. Endothelial progenitor cells: more than an inflammatory response?. Arterioscler Thromb Vasc Biol 24 (2004) 834-838
9. Hristov M, Weber C. Ambivalence of progenitor cells in vascular repair and plaque stability. Curr Opin Lipidol; in press.
10. Zengin E., Chalajour F., Gehling U.M., et al. Vascular wall resident progenitor cells: a source for postnatal vasculogenesis. Development 133 (2006) 1543-1551
11. Harraz M., Jiao C., Hanlon H.D., Hartley R.S., and Schatteman G.C. CD34-blood-derived human endothelial cell progenitors. Stem Cells 19 (2001) 304-312
12. Elsheikh E., Uzunel M., He Z., et al. Only a specific subset of human peripheral-blood monocytes has endothelial-like functional capacity. Blood 106 (2005) 2347-2355
13. Venneri M.A., De Palma M., Ponzoni M., et al. Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer. Blood 109 (2007) 5276-5285
14. Hristov M., Zernecke A., Bidzhekov K., et al. Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury. Circ Res 100 (2007) 590-597
15. Kalka C., Masuda H., Takahashi T., Gordon R., Tepper O., Gravereaux E., et al. Vascular endothelial growth factor165 gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res 86 (2000) 1198-1202
16. Rehman J., Li J., Orschell C.M., and March K.L. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107 (2003) 1164-1169
17. Lin Y., Weisdorf D.J., Solovey A., and Hebbel R.P. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 105 (2000) 71-77
18. Gulati R., Jevremovic D., Peterson T.E., Chatterjee S., Shah V., Vile R.G., et al. Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ Res 93 (2003) 1023-1025
19. Yoder M.C., Mead L.E., Prater D., Krier T.R., Mroueh K.N., Li F., et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109 (2007) 1801-1809
20. Wang C.H., Cherng W.J., Yang N.I., et al. Late-outgrowth endothelial cells attenuate intimal hyperplasia contributed by mesenchymal stem cells after vascular injury. Arterioscler Thromb Vasc Biol 28 (2008) 54-60
21. Petit I., Jin D., and Rafii S. The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol 28 (2007) 299-307
22. Heissig B., Hattori K., Dias S., et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109 (2002) 625-637
23. Schober A., Karshovska E., Zernecke A., and Weber C. SDF-1α-mediated tissue repair by stem cells: a promising tool in cardiovascular medicine?. Trends Cardiovasc Med 16 (2006) 103-108
24. Damås J.K., Waehre T., Yndestad A., et al. Stromal cell-derived factor-1alpha in unstable angina: potential antiinflammatory and matrix-stabilizing effects. Circulation 106 (2002) 36-42
25. Ceradini D.J., Kulkarni A.R., Callaghan M.J., et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10 (2004) 858-864
26. Karshovska E., Zernecke A., Sevilmis G., et al. Expression of HIF-1α in injured arteries controls SDF-1alpha mediated neointima formation in apolipoprotein E deficient mice. Arterioscler Thromb Vasc Biol 27 (2007) 2540-2547
27. Liehn E.A., Schober A., and Weber C. Blockade of keratinocyte-derived chemokine inhibits endothelial recovery and enhances plaque formation after arterial injury in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 24 (2004) 1891-1896
28. Schober A., Bernhagen J., Thiele M., et al. Stabilization of atherosclerotic plaques by blockade of macrophage migration inhibitory factor after vascular injury in apolipoprotein E-deficient mice. Circulation 109 (2004) 380-385
29. Bernhagen J., Krohn R., Lue H., et al. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 13 (2007) 587-596
30. Hristov M., Zernecke A., Liehn E.A., and Weber C. Regulation of endothelial progenitor cell homing after arterial injury. Thromb Haemost 98 (2007) 274-277
31. Fujiyama S., Amano K., Uehira K., et al. Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells. Circ Res 93 (2003) 980-989
32. Chavakis E., Aicher A., Heeschen C., et al. Role of β2-integrins for homing and neovascularization capacity of endothelial progenitor cells. J Exp Med 201 (2005) 63-72
33. Duan H., Cheng L., Sun X., et al. LFA-1 and VLA-4 involved in human high proliferative potential-endothelial progenitor cells homing to ischemic tissue. Thromb Haemost 96 (2006) 807-815
34. Foubert P., Silvestre J.S., Souttou B., et al. PSGL-1-mediated activation of EphB4 increases the proangiogenic potential of endothelial progenitor cells. J Clin Invest 117 (2007) 1527-1537
35. Aicher A., Heeschen C., Mildner-Rihm C., et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 9 (2003) 1370-1376
36. Bahlmann F.H., De Groot K., Spandau J.M., et al. Erythropoietin regulates endothelial progenitor cells. Blood 103 (2004) 921-926
37. Honold J., Lehmann R., Heeschen C., et al. Effects of granulocyte colony simulating factor on functional activities of endothelial progenitor cells in patients with chronic ischemic heart disease. Arterioscler Thromb Vasc Biol 26 (2006) 2238-2243
38. Gill M., Dias S., Hattori K., et al. Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ Res 88 (2001) 167-174
39. Valgimigli M., Rigolin G.M., Fucili A., Porta M.D., Soukhomovskaia O., Malagutti P., et al. CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation 110 (2004) 1209-1212
40. Shintani S., Murohara T., Ikeda H., Ueno T., Honma T., Katoh A., et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103 (2001) 2776-2779
41. Massa M., Rosti V., Ferrario M., Campanelli R., Ramajoli I., Rosso R., et al. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 105 (2005) 199-206
42. Boilson B.A., Kiernan T.J., Harbuzariu A., Nelson R.E., Lerman A., and Simari R.D. Circulating CD34+ cell subsets in patients with coronary endothelial dysfunction. Nat Clin Pract Cardiovasc Med 5 (2008) 489-496
43. Vasa M., Fichtlscherer S., Adler K., et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103 (2001) 2885-2890
44. Walter D.H., Rittig K., Bahlmann F.H., et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105 (2002) 3017-3024
45. Gensch C., Clever Y.P., Werner C., Hanhoun M., Böhm M., and Laufs U. The PPAR-gamma agonist pioglitazone increases neoangiogenesis and prevents apoptosis of endothelial progenitor cells. Atherosclerosis 192 (2007) 67-74
46. Hristov M., Fach C., Becker C., et al. Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment. Atherosclerosis 192 (2007) 413-420
47. Deschaseaux F., Selmani Z., Falcoz P.E., et al. Two types of circulating endothelial progenitor cells in patients receiving long term therapy by HMG-CoA reductase inhibitors. Eur J Pharmacol 562 (2007) 111-118
48. Redondo S., Hristov M., Gordillo-Moscoso A.A., et al. High-reproducible flow cytometric endothelial progenitor cell determination in human peripheral blood as CD34+/CD144+/CD3- lymphocyte sub-population. J Immunol Method 335 (2008) 21-27
49. Sugiura T., Kondo T., Kureishi-Bando Y., Numaguchi Y., Yoshida O., Dohi Y., Kimura G., Ueda R., Rabelink T.J., and Murohara T. Nifedipine improves endothelial function. Role of endothelial progenitor cells. Hypertension 52 (2008) 1-8
50. Wang C.H., Verma S., Hsieh I.C., Chen Y.J., Kuo L.T., Yang N.I., et al. Enalapril increases ischemia-induced endothelial progenitor cell mobilization through manipulation of the CD26 system. J Mol Cell Cardiol 41 (2006) 34-43
51. Rauscher F.M., Goldschmidt-Clermont P.J., Davis B.H., Wang T., Gregg D., Ramaswami P., et al. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 108 (2003) 457-463
52. Hu Y., Davison F., Zhang Z., and Xu Q. Endothelial replacement and angiogenesis in arteriosclerotic lesions of allografts are contributed by circulating progenitor cells. Circulation 108 (2003) 3122-3127
53. Hristov M., and Weber C. The therapeutic potential of progenitor cells in ischemic heart disease-past, present and future. Basic Res Cardiol 101 (2006) 1-7
54. Leor J., and Marber M. Endothelial progenitors: a new Tower of Babel?. J Am Coll Cardiol 48 (2006) 1588-1590
55. Werner N., and Nickenig G. Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy?. Arterioscler Thromb Vasc Biol 26 (2006) 257-266
56. Murphy C., Kanaganayagam G.S., Jiang B., Chowienczyk P.J., Zbinden R., Saha M., et al. Vascular dysfunction and reduced circulating endothelial progenitor cells in young healthy UK South Asian men. Arterioscler Thromb Vasc Biol 27 (2007) 936-942
57. George J., Goldstein E., Abashidze S., Deutsch V., Shmilovich H., Finkelstein A., et al. Circulating endothelial progenitor cells in patients with unstable angina: association with systemic inflammation. Eur Heart J 25 (2004) 1003-1008
58. Güven H., Shepherd R.M., Bach R.G., et al. The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease. J Am Coll Cardiol 48 (2006) 1579-1587
59. Xiao Q., Kiechl S., Patel S., et al. Endothelial progenitor cells, cardiovascular risk factors, cytokine levels and atherosclerosis-results from a large population-based study. PLoS ONE 2 (2007) e975
60. George J., Afek A., Abashidze A., et al. Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 25 (2005) 2636-2641
61. Smith C., Damås J.K., Otterdal K., et al. Increased levels of neutrophil-activating peptide-2 in acute coronary syndromes: possible role of platelet-mediated vascular inflammation. J Am Coll Cardiol 48 (2006) 1591-1599
62. Breland U.M., Halvorsen B., Hol J., et al. A potential role of the CXC chemokine GROα in atherosclerosis and plaque destabilization. Downregulatory effects of statins. Arterioscler Thromb Vasc Biol 28 (2008) 1005-1011
63. Boisvert W.A., Santiago R., Curtiss L.K., and Terkeltaub R.A. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J Clin Invest 101 (1998) 353-363